Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
D6.3 Report on the EURO-NMD Newsletters
Prominent Canadian researcher in Denmark: Why I left a top job in California
Management — NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
ALS Therapy Developer NMD Pharma Obtains $47 Million in New Financing
NMD Pharma A/S | LinkedIn
NMD Pharma company information, funding & investors | Dealroom.co
Management — NMD Pharma
Tunge pengetanke klar til nye investeringer i aarhusiansk biotekselskab
Report
EAMDA 47th AGA successfully finished – EAMDA – European Alliance of Neuromuscular Disorders Associations
NMD Pharma company information, funding & investors | Dealroom.co
Argenx køber amerikansk guldkupon til middel, som NMD Pharma skal konkurrere mod
Management — NMD Pharma
NMD Pharma
NMD Pharma company information, funding & investors | Dealroom.co
Catabasis on Twitter: "Our team is in Copenhagen, Denmark to participate in the 24th Annual Congress of the World Muscle Society and share updates on #edasalonexent.… https://t.co/qBXi9jeum0"
NMD Pharma A/S | LinkedIn
Management — NMD Pharma
NMD Pharma A/S | LinkedIn
TREAT-NMD Partner Newsletter No. 18 6 July 2007 and Club of Interest Newsletter No. 12